NASDAQ: CSBR
Champions Oncology Inc Stock Ownership - Who owns Champions Oncology?

Insider buying vs selling

Have Champions Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joel AckermanDirector2024-10-3116,667$5.43
$90.50kBuy
Joel AckermanDirector2024-10-3188,470$2.10
$185.79kBuy

1 of 1

CSBR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CSBR insiders and whales buy or sell their stock.

CSBR Shareholders

What type of owners hold Champions Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael Maurice Brown169.54%23,442,589$179.57MInsider
Ravi Viswanathan135.61%18,750,000$143.63MInsider
David M. Mott135.61%18,750,000$143.63MInsider
Forest Baskett135.61%18,750,000$143.63MInsider
Harry R. Weller135.61%18,750,000$143.63MInsider
Peter W. Sonsini135.61%18,750,000$143.63MInsider
Krishna Kittu Kolluri135.61%18,750,000$143.63MInsider
Patrick J. Kerins135.61%18,750,000$143.63MInsider
Scott D. Sandell135.61%18,750,000$143.63MInsider
Peter J. Barris135.61%18,750,000$143.63MInsider

1 of 3

CSBR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSBR2.00%98.00%Net Buying
NKTR82.53%17.47%Net SellingNet Selling
NTHI0.31%91.78%Net BuyingNet Buying
EXOZ0.56%99.44%Net Buying
ATOS21.95%11.04%Net BuyingNet Buying

Champions Oncology Stock Ownership FAQ

Who owns Champions Oncology?

Champions Oncology (NASDAQ: CSBR) is owned by 42.80% institutional shareholders, 2,093.50% Champions Oncology insiders, and 0.00% retail investors. Michael Maurice Brown is the largest individual Champions Oncology shareholder, owning 23.44M shares representing 169.54% of the company. Michael Maurice Brown's Champions Oncology shares are currently valued at $179.57M.

If you're new to stock investing, here's how to buy Champions Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.